A Varier Radhika

Title: A Varier Radhika: Innovator in Histone Acetyltransferase Inhibition

Introduction

A Varier Radhika is a notable inventor based in Coimbatore, India. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for histone acetyltransferases. His work has implications for cancer research and therapeutic development.

Latest Patents

Radhika holds a patent titled "Polyisoprenylated benzophenones and their isomers as inhibitors of histone acetyltransferases and uses thereof." This patent describes the purification of prenylated benzophenones from the fruit rinds of specific species and evaluates their effectiveness as inhibitors for histone acetyltransferases p300 and PCAF. The findings indicate that these compounds are potent HAT inhibitors, with IC-1 1 μM for p300 and IC-15 15 μM for pCAF. The inhibitors significantly repress p300 HAT-dependent transcriptional activation from in vitro assembled chromatin templates, while having no effect on transcription from DNA. These results suggest that the compounds could be specific to HATs, making them useful as biological switching molecules for evaluating the role of p300 and PCAF in cellular functions. Furthermore, they may serve as new chemical entities for the development of anticancer drugs.

Career Highlights

Radhika is affiliated with the Jawaharlal Nehru Centre for Advanced Scientific Research, where he conducts his research. His work has garnered attention for its potential applications in cancer treatment and understanding cellular mechanisms.

Collaborations

He has collaborated with notable colleagues, including Kundu Tapas Kumar and Karanam Balasubramanyam, to advance research in his field.

Conclusion

A Varier Radhika's innovative work in the development of histone acetyltransferase inhibitors highlights his contributions to biochemistry and cancer research. His patent and ongoing research may pave the way for new therapeutic strategies in the fight against cancer.